2021 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
2023 (v1)Publication
No description
Uploaded on: February 11, 2024 -
2016 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2024 (v1)PublicationLIFE-THREATENING EVEROLIMUS-ASSOCIATED EROSIVE-HEMORRHAGIC GASTROPATHY IN A LIVER TRANSPLANT PATIENT
No description
Uploaded on: November 1, 2024 -
2017 (v1)Publication
The serum levels of soluble HLA class I antigens (sHLA-A, -B, -C and sHLA-G) were determined in 40 HCV genotype 1-infected patients before (T 0), after 3, 6, and 12 months (T 3, T 6, and T 12) of pegylated-IFN-α plus ribavirin therapy and 6 months (T 18) after the end of treatment. Twenty patients were sustained virological responders (SVR),...
Uploaded on: March 27, 2023 -
2023 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2015 (v1)Publication
Objective. To investigate the relationship between insulin resistance and viral load decay in nondiabetic and noncirrhotic genotype 1 chronic HCV patients during peginterferon and ribavirin treatment and the possible influence of BMI and leptin as metabolic confounders. Methods. 75 consecutive noncirrhotic, nonobese, and nondiabetic patients...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2023 (v1)Publication
Background & AimsPatients with cirrhosis are considered in a haemostatic balance, though weaker than in normal subjects. In these patients, however, the use of pharmacological prophylaxis for venous thromboembolism (VTE) remains controversial. Therefore, in this study, we aimed to assess the safety and efficacy of VTE prophylaxis in patients...
Uploaded on: February 14, 2024